This inventor holds 9 USPTO granted patents. Top assignees: Oncotech, Inc., University of Illinois, Onotech, Inc.. Active years: 1995-2008.
Location History:
- Chicago, IL (US) (1995 - 1998)
- Irvine, CA (US) (1999 - 2008)
Company Filing History:
4 out of 12 
4 out of 2,421 
1 out of 1 Years Active: 1995-2008
Title: The Innovative Contributions of Eugene Mechetner
Introduction
Eugene Mechetner is a prominent inventor based in Irvine, CA, known for his significant contributions to cancer research and treatment. With a total of 9 patents, he has developed groundbreaking methods that enhance the prognosis and diagnosis of cancer, as well as improve therapeutic strategies for patients.
Latest Patents
Among his latest patents, one notable invention is focused on methods for cancer prognosis and diagnosis. This invention provides techniques for assessing prognosis, diagnosis, staging, and disease progression in human cancer patients by analyzing the expression levels of various genes that differ in chemotherapeutic drug-resistant and drug-sensitive tumor cells. Another significant patent involves methods and reagents for preparing and using immunological agents specific for P-glycoprotein. This invention addresses the challenges of multidrug resistance in cancer patients undergoing chemotherapy by developing immunological reagents that target specific forms of P-glycoprotein, enhancing the identification and characterization of anticancer compounds.
Career Highlights
Eugene Mechetner has had a distinguished career, working with notable organizations such as Oncotech, Inc. and the University of Illinois. His work has been instrumental in advancing cancer treatment methodologies and improving patient outcomes.
Collaborations
Throughout his career, Eugene has collaborated with esteemed colleagues, including John P. Fruehauf and Igor B. Roninson. These partnerships have contributed to the development of innovative solutions in cancer research.
Conclusion
Eugene Mechetner's contributions to cancer research through his patents and collaborations have made a significant impact in the field. His innovative methods continue to pave the way for advancements in cancer prognosis and treatment.